The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

US FDA LOGO IN BLACK OVER A WHITE BACKGROUND. | Credit: US Food and Drug Administration
FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism

October 8th 2024

The FDA's decision to issue a CRL was announced on October 08, 2024 and cites issues with the timing of the facility inspection.

Pam Taub, MD | Credit: UC San Diego Health
Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial

October 8th 2024

HCPLive Endocrinology Month in Review September 2024 thumbnail
Endocrinology Month in Review: September 2024

October 6th 2024

FDA Decisions to Watch in Q4 2024 thumbnail
5 FDA Decisions to Watch in Q4 2024

October 4th 2024

TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency| Image Credit: US Food and Drug Administration
TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency

September 30th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Video Series
Video Interviews
Podcasts
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
John Buse, MD, PhD | Credit: UNC School of Medicine
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.